423 studies found for:    "Keratoconjunctivitis sicca"
Show Display Options
Rank Status Study
1 Recruiting Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca
Conditions: Keratoconjunctivitis Sicca;   Dry Eye Syndrome
Intervention: Drug: dexamethasone, artificial tears
2 Completed
Has Results
Dry Eye Assessment and Management: Feasibility Study
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: Omega-3 EFA Supplement;   Drug: Olive Oil
3 Completed Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: AT01;   Drug: AT02;   Drug: AT03;   Drug: AT04
4 Completed Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
Conditions: Keratoconjunctivitis Sicca;   Dry Eye
Interventions: Drug: rebamipide 2% ophthalmic suspension;   Drug: placebo eye drops
5 Completed Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: rebamipide 2% ophthalmic suspension;   Drug: placebo eye drops
6 Completed Safety and Efficacy Study of SAR 1118 to Treat Dry Eye
Conditions: Dry Eye;   Keratoconjunctivitis Sicca
Intervention: Drug: Lifitegrast
7 Completed Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
Conditions: Dry Eye Disease;   Keratoconjunctivitis Sicca
Interventions: Drug: Lotemax;   Drug: Restasis
8 Completed
Has Results
Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD);   Drug: sodium hyaluronate 0.18% (VISMED® Multi)
9 Completed Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Pimecrolimus
10 Active, not recruiting Lotemax® Gel 0.5% and Restasis 0.05% in Subjects With Mild or Moderate Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: Lotemax Gel + Restasis;   Drug: Lotemax Gel;   Drug: Restasis
11 Completed
Has Results
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: CF101;   Drug: Placebo
12 Completed
Has Results
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
Conditions: Dry Eye Syndrome;   Dry Eye
Interventions: Drug: Thymosin beta 4;   Drug: Placebo
13 Completed Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
Condition: Keratoconjunctivitis Sicca
Interventions: Dietary Supplement: Hydroeye;   Other: Inactive Capsule
14 Completed Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
Conditions: Keratoconjunctivitis Sicca;   Sjogren's Syndrome
Intervention: Drug: Cyclosporin A
15 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
16 Completed Study of Rebamipide Eye Drops to Treat Dry Eye
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: Rebamipide
17 Not yet recruiting A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: carboxymethylcellulose 0.5%/glycerin 0.9%;   Drug: sodium hyaluronate 0.18%
18 Recruiting To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: R348 Ophthalmic Solution, 0.2%;   Drug: R348 Ophthalmic Solution, 0.5%;   Drug: Placebo
19 Completed Trial of CF101 to Treat Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: CF101
20 Recruiting A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: SkQ1;   Drug: Placebo SkQ1 (Vehicle)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years